K, C., D, R., I, S., & G, K. (2024). Resolution of PTHrP-Mediated Hypercalcemia Following Treatment with Dual BRAF/MEK Inhibition for BRAFV600E-Positive Metastatic Ameloblastoma. Calcified tissue international, 114(4), 444. https://doi.org/10.1007/s00223-023-01177-x
Chicago Style (17th ed.) CitationK, Corbett, Ruether D, Seiden-Long I, and Kline G. "Resolution of PTHrP-Mediated Hypercalcemia Following Treatment with Dual BRAF/MEK Inhibition for BRAFV600E-Positive Metastatic Ameloblastoma." Calcified Tissue International 114, no. 4 (2024): 444. https://doi.org/10.1007/s00223-023-01177-x.
MLA (9th ed.) CitationK, Corbett, et al. "Resolution of PTHrP-Mediated Hypercalcemia Following Treatment with Dual BRAF/MEK Inhibition for BRAFV600E-Positive Metastatic Ameloblastoma." Calcified Tissue International, vol. 114, no. 4, 2024, p. 444, https://doi.org/10.1007/s00223-023-01177-x.